Skip to main content

Market Overview

ResMed Inc. (NYSE: RMD)

243.13 +2.04 (0.85%)

Analyst Ratings

DateResearch FirmActionCurrentPT
6/22/21BairdInitiates Coverage OnNeutral240.0
6/21/21NeedhamMaintainsBuy267.0
6/16/21B of A SecuritiesDowngradesUnderperform221.0
6/15/21OppenheimerMaintainsOutperform270.0
5/21/21JP MorganUpgradesOverweight219.0
5/11/21CitigroupUpgradesBuy
3/16/21NeedhamUpgradesBuy229.0
5/01/20OppenheimerUpgradesOutperform200.0
2/03/20CLSAInitiates Coverage OnUnderperform
1/31/20UBSDowngradesNeutral174.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter